Literature DB >> 27352994

CXCR4 antagonism overcomes diabetic stem cell mobilopathy.

Moufida Ben Nasr1, Paolo Fiorina2.   

Abstract

Entities:  

Keywords:  CXCR4; Diabetes; Immunoregulation; Mobilopathy; Stem cells; Transplantation

Mesh：

Substances：

Year:  2016        PMID： 27352994     DOI： 10.1016/j.atherosclerosis.2016.06.025

Source DB:  PubMed          Journal:  Atherosclerosis        ISSN： 0021-9150            Impact factor:   5.162


× No keyword cloud information.
  2 in total

1.  MIF inhibition interferes with the inflammatory and T cell-stimulatory capacity of NOD macrophages and delays autoimmune diabetes onset.

Authors:  Hannelie Korf; Laura Breser; Jelter Van Hoeck; Janet Godoy; Dana P Cook; Benoit Stijlemans; Elien De Smidt; Carolien Moyson; João Paulo Monteiro Carvalho Mori Cunha; Virginia Rivero; Conny Gysemans; Chantal Mathieu
Journal:  PLoS One       Date:  2017-11-02       Impact factor: 3.240

2.  Regimen-dependent synergism and antagonism of treprostinil and vildagliptin in hematopoietic cell transplantation.

Authors:  Eva Zebedin-Brandl; Madeleine Themanns; Zahra Kazemi; Shahrooz Nasrollahi-Shirazi; Marion Mussbacher; Elizabeth Heyes; Katrin Meissl; Michaela Prchal-Murphy; Wolfgang Strohmaier; Guenther Krumpl; Michael Freissmuth
Journal:  J Mol Med (Berl)       Date:  2019-12-24       Impact factor: 4.599
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.